Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 51,679 |
|
|||||
| News | - | ||||||
| Day High | 17.87 | Low High |
|||||
| Day Low | 17.52 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Indivior PLC | INDV | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.125 | 0.71% | 17.685 | 13:18:40 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 17.80 | 17.52 | 17.87 | 17.56 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 756 | 51,679 | $ 17.69 | $ 914,179 | - | 14.3809 - 26.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:18:06 | 5 | $ 17.70 | USD |
Indivior PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.93B | 135.27M | - | 1.09B | 2M | 0.01 | 964.86 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Indivior News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INDV Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 19.11 | 19.13 | 17.12 | 17.66 | 202,980 | -1.43 | -7.46% |
| 1 Month | 21.40 | 22.53 | 17.12 | 19.37 | 141,404 | -3.72 | -17.36% |
| 3 Months | 17.52 | 23.22 | 16.44 | 20.18 | 143,431 | 0.165 | 0.94% |
| 6 Months | 19.24 | 23.22 | 14.3809 | 19.16 | 92,667 | -1.56 | -8.08% |
| 1 Year | 26.50 | 26.50 | 14.3809 | 19.49 | 57,559 | -8.82 | -33.26% |
| 3 Years | 26.50 | 26.50 | 14.3809 | 19.49 | 57,559 | -8.82 | -33.26% |
| 5 Years | 26.50 | 26.50 | 14.3809 | 19.49 | 57,559 | -8.82 | -33.26% |
Indivior Description
| Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. |
